Ja Hye Kim

Ja Hye Kim

Auto-generated profile, based on publicly available information

Ja Hye Kim

Department of Pediatrics, Asan Medical Center Children’s Hospital, University of Ulsan College of Medicine, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

15Years (2012-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2017 in Molecular and Cellular Endocrinology
Verified
Journal Article
Closed access
JKJa Hye Kim
Ja Hye Kim
EKEungu Kang
Eungu Kang
SHSun Hee Heo
Sun Hee Heo
GKGu-Hwan Kim
Gu-Hwan Kim
JJJa-Hyun Jang
Ja-Hyun Jang
JCJin-Ho Choi
Jin-Ho Choi

19 October 2015 in Clinical Endocrinology
Verified
Journal Article
Closed access
PDF file
JKJa Hye Kim
Ja Hye Kim
YSYoung‐Lim Shin
Young‐Lim Shin
SYSeung Yang
Seung Yang
CCChong Kun Cheon
Chong Kun Cheon
JCJa Hyang Cho
Ja Hyang Cho
HYHan‐Wook Yoo
Han‐Wook Yoo

23 June 2016 in Journal of Human Genetics
Verified
Journal Article
Closed access
JKJa Hye Kim
Ja Hye Kim
BLBeom Hee Lee
Beom Hee Lee
JCJa Hyang Cho
Ja Hyang Cho
EKEungu Kang
Eungu Kang
JCJin-Ho Choi
Jin-Ho Choi
HYHan-Wook Yoo
Han-Wook Yoo

1 January 2012 in Korean Journal of Pediatrics
Verified
Journal Article
Open access
PDF file
JKJa Hye Kim
Ja Hye Kim
JYJeong Jin Yu
Jeong Jin Yu
JLJina Lee
Jina Lee
MKMi-Na Kim
Mi-Na Kim
HKHong Ki Ko
Hong Ki Ko
JKJae-Kon Ko
Jae-Kon Ko
The purpose of this prospective case-control study was to survey the detection rate of respiratory viruses in children with Kawasaki disease (KD) by using multiplex reverse transcriptase-polymerase chain reaction (RT-PCR), and to investigate the clinical implications of the prevalence of respiratory viruses during the acute phase of KD. RT-PCR assays were carried out to screen for the presence of respiratory syncytial virus A and B, adenovirus, rhinovirus, parainfluenza viruses 1 to 4, influenza virus A and B, metapneumovirus, bocavirus, coronavirus OC43/229E and NL63, and enterovirus in nasopharyngeal secretions of 55 KD patients and 78 control subjects. Virus detection rates in KD patients and control subjects were 32.7% and 30.8%, respectively (P=0.811). However, there was no significant association between the presence of any of the 15 viruses and the incidence of KD. Comparisons between the 18 patients with positive RT-PCR results and the other 37 KD patients revealed no significant differences in terms of clinical findings (including the prevalence of incomplete presentation of the disease) and coronary artery diameter. A positive RT-PCR for currently epidemic respiratory viruses should not be used as an evidence against the diagnosis of KD. These viruses were not associated with the incomplete presentation of KD and coronary artery dilatation.

13 June 2014 in Metabolic Brain Disease
Verified
Journal Article
Closed access
PDF file
JKJa Hye Kim
Ja Hye Kim
BLBeom Hee Lee
Beom Hee Lee
YKYoo-Mi Kim
Yoo-Mi Kim
JCJin-Ho Choi
Jin-Ho Choi
GKGu-Hwan Kim
Gu-Hwan Kim
HYHan-Wook Yoo
Han-Wook Yoo

30 June 2023 in Annals of Pediatric Endocrinology & Metabolism
Verified
Journal Article
Open access
PDF file
JKJa Hye Kim
Ja Hye Kim
GKGu-Hwan Kim
Gu-Hwan Kim
HYHan-Wook Yoo
Han-Wook Yoo
JCJin-Ho Choi
Jin-Ho Choi
Congenital adrenal hyperplasia (CAH) is a group of autosomally recessive disorders that result from impaired synthesis of glucocorticoid and mineralocorticoid. Most cases (~95%) are caused by mutations in the CYP21A2 gene, which encodes steroid 21-hydroxylase. CAH patients manifest a wide phenotypic spectrum according to their degree of residual enzyme activity. CYP21A2 and its pseudogene (CYP21A1P) are located 30 kb apart in the 6q21.3 region and share approximately 98% of their sequences in the coding region. Both genes are aligned in tandem with the C4, SKT19, and TNX genes, forming 2 segments of the RCCX modules that are arranged as STK19-C4A-CYP21A1P-TNXA-STK19B-C4B-CYP21A2-TNXB. The high sequence homology between the active gene and pseudogene leads to frequent microconversions and large rearrangements through intergenic recombination. The TNXB gene encodes an extracellular matrix glycoprotein, tenascin-X (TNX), and defects in TNXB cause Ehlers-Danlos syndrome. Deletions affecting both CYP21A2 and TNXB result in a contiguous gene deletion syndrome known as CAH-X syndrome. Because of the high homology between CYP21A2 and CYP21A1P, genetic testing for CAH should include an evaluation of copy number variations, as well as Sanger sequencing. Although it poses challenges for genetic testing, a large number of mutations and their associated phenotypes have been identified, which has helped to establish genotype-phenotype correlations. The genotype is helpful for guiding early treatment, predicting the clinical phenotype and prognosis, and providing genetic counseling. In particular, it can help ensure proper management of the potential complications of CAH-X syndrome, such as musculoskeletal and cardiac defects. This review focuses on the molecular pathophysiology and genetic diagnosis of 21-hydroxylase deficiency and highlights genetic testing strategies for CAH-X syndrome.